Synthesis of cephalosporin compounds
US-2017275300-A1 · Sep 28, 2017 · US
US10214543B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10214543-B2 |
| Application number | US-201515540283-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 18, 2015 |
| Priority date | Dec 30, 2014 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are methods for the manufacture of ceftolozane and related compounds, as well as compositions comprising the same.
Opening claim text (preview).
What is claimed is: 1. A process of making a compound of formula (V′): comprising admixing a compound of formula (III′): and a compound of formula (IV′): in a solvent to provide the compound of formula (V′), wherein: P 1 and P 2 are each independently an acid-labile nitrogen protecting group, P 3 and P 4 are each independently an acid-labile oxygen protecting group, X − is a pharmaceutically acceptable salt, Y is Cl or Br; the molar ratio of the compound of formula (IV′) to the compound of formula (III′) is from 1.0:1 to 1.3:1; and the solvent is purged with nitrogen at from 0.2 m 3 /h to 1.2 m 3 /h per kilogram of the compound of formula (III′). 2. A process of making a compound of formula (V′): comprising admixing a compound of formula (III′): and a compound of formula (IV′): in a solvent to provide the compound of formula (V′), wherein: P 1 and P 2 are each independently an acid-labile nitrogen protecting group, P 3 and P 4 are each independently an acid-labile oxygen protecting group, X − is a pharmaceutically acceptable salt, Y is Cl, Br or I; the temperature of the admixture is from 25° C. to 32° C.; and the solvent is purged with nitrogen at from 0.2 m 3 /h to 1.2 m 3 /h per kilogram of the compound of formula (III′). 3. A process of making a compound of formula (V′): comprising admixing a compound of formula (III′): and a compound of formula (IV′): in a solvent to provide the compound of formula (V′), wherein: P 1 and P 2 are each independently an acid-labile nitrogen protecting group, P 3 and P 4 are each independently an acid-labile oxygen protecting group, X − is a pharmaceutically acceptable salt, Y is Cl, Br or I; and the solvent is purged with nitrogen at from 0.2 m 3 /h to 1.2 m 3 /h per kilogram of the compound of formula (III′). 4. The process of claim 1 , 2 or 3 , wherein P 1 is tert-butoxycarbonyl. 5. The process of claim 1 , 2 or 3 , wherein P 2 is triphenylmethyl. 6. The process of claim 1 , 2 or 3 , wherein P 3 is 4-methoxybenzyl. 7. The process of claim 1 , 2 or 3 , wherein P 4 is tert-butyl. 8. The process of claim 1 , 2 or 3 , wherein X − is trifluoroacetate, bromide, chloride, iodide, or methanesulfonate. 9. The process of claim 1 , 2 or 3 , wherein Y is Cl. 10. The process of claim 1 , 2 or 3 , wherein the admixture further comprises 1, 3-bis(trimethylsilyl)urea. 11. The process of claim 1 , 2 or 3 , wherein the admixture further comprises potassium iodide. 12. The process of claim 1 , 2 or 3 , wherein the temperature is from 27° C. to 30° C. 13. The process of claim 1 , 2 or 3 , wherein the solvent is a polar aprotic solvent. 14. The process of claim 1 , 2 or 3 , wherein the solvent comprises N-methylpyrrolidinone. 15. The process of claim 1 , 2 or 3 , wherein the solvent is purged with nitrogen at from 0.3 m 3 /h to 1.2 m 3 /h per kilogram of the compound of formula (III′). 16. The process of claim 1 , 2 or 3 , wherein the molar ratio of the compound of formula (IV′) to the compound of formula (III′) is 1.2:1. 17. The process of claim 1 , 2 or 3 , wherein the compound of formula (V′) has the structure of compound (V): the compound of formula (III′) has the structure of compound (III): and the compound of formula (IV′) has the structure of compound (IV): 18. The process of claim 1 , 2 or 3 , further comprising making a compound of formula (Vb′): comprising contacting the compound of formula (V′) with an acid of formula HX, at a temperature of from 18° C. to 22° C., to provide the compound of formula (Vb′), wherein HX is trifluoroacetic acid, hydrogen bromide, hydrogen chloride, hydrogen iodide, or methanesulfonic acid; and X′ is trifluoroacetate, bromide, chloride, iodide, or methanesulfonate. 19. The process of claim 18 , wherein the amount of the acid is from 4.5 L to 6.0 L per kilogram of the compound of formula (V′). 20. The process of claim 18 , further comprising separating the compound of formula (Vb′) at a temperature of from −40° C. to −30° C.
with the 7-amino radical acylated by carboxylic acids containing hetero rings · CPC title
of amide groups · CPC title
of amino groups · CPC title
Introduction of protecting groups or activating groups, not provided for in the preceding groups · CPC title
containing three or more hetero rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.